---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-031054"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:46:29.710258+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Tivic Health enters new CEO employment agreement with Jennifer Ernst; base salary $325K

## Summary
- Jennifer Ernst, CEO, enters new employment agreement effective Oct 8, 2025, replacing prior offer letter.
- Base salary of $325,000 per annum; eligible for annual bonus up to 50% of base salary at Board discretion.
- Severance: 12 months of base salary continuation, COBRA coverage, and continued equity vesting if terminated without cause or for good reason.
- Severance conditioned on signing a release; no severance for voluntary quit (except good reason), cause, death, or disability.
- Employment remains 'at will'; prior confidentiality and arbitration agreements remain in force.

## SEC filing metadata
- accession: 0001437749-25-031054
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000143774925031054/0001437749-25-031054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000143774925031054/tivc20251010_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-031054
- JSON: https://secwatch.observer/filing/0001437749-25-031054.json
- Plain text: https://secwatch.observer/filing/0001437749-25-031054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.